logo
Products
Technologies
Applications
Services
Resources
Selection Guides
About
iFluor® 680 Anti-human CD19 Antibody
HIB19
HIB19 is an anti-human monoclonal antibody that recognizes the CD19 antigen. CD19 (also known as CVID3) is a 95 kD glycoprotein that is located on the surface of cells like stem cells, dendritic cells and B cells. In certain organisms, CD19 promotes release of sequestered calcium ion into cytosol, plays a role in the upregulation of phosphatidylinositol 3-kinase activity and acts to positively regulate protein kinase B signaling. In addition, it is a member of critical cellular pathways, for example, the antigen receptor-mediated signaling pathway and B cell receptor signaling pathway. From a research standpoint, it is of biological interest due to its association with key macromolecules/ligands such as lyn. CD19 is a very popular antibody target, with over 36000 publications in the last decade. CD19 is often used in flow cytometry applications as a phenotypic marker for differentiation of cell types, specifically in the study of immunology and costimulatory molecules. This antibody was purified through affinity chromatography and conjugated to iFluor® 680 (ex/em = 684/701 nm).
product image
product image
CatalogSize
Price
Quantity
101920I0100 tests
Price
101920I1500 tests
Price
 
Antibody properties

Other namesB4
CloneHIB19
Hostmouse
Reactivityhuman
ApplicationFlow Cytometry (FACS); Fluorescence Imaging
Spectral properties

Correction factor (260 nm)0.097
Correction factor (280 nm)0.094
Extinction coefficient (cm -1 M -1)
220000
1
Excitation (nm)684
Emission (nm)701
Quantum yield
0.23
1
Storage, safety and handling

H-phraseH303, H313, H333
Hazard symbolXN
Intended useResearch Use Only (RUO)
R-phraseR20, R21, R22
Contact us

Telephone
Fax
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
Technical SupportContact us
Request quotationRequest
Purchase orderSend to sales@aatbio.com
ShippingStandard overnight for United States, inquire for international
Page updated on October 16, 2025